Breaking News Instant updates and real-time market news.

TXMD

TherapeuticsMD

09:42
12/01/16
12/01
09:42
12/01/16
09:42

TherapeuticsMD recent weakness an attractive buying opportunity, say Goldman

Goldman analsyt Jami Rubin said pressure to remove the black box label for TherapeuticsMD's Yuvexxy is growing as indicated by a letter from members of Congress to the FDA on October 11. The analyst said it represents a growing movement to increase accessibility for low-dose estrogen products that pose limited systemic risk. Rubin views TherapeuticsMD's recent share weakness as an attractive buying opportunity ahead of 2017 catalysts and upcoming data from the Phase III RELENISH study. The analyst rates TherapeuticsMD a Buy with a $10.50 price target.

TXMD TherapeuticsMD

11/22/16
JEFF
11/22/16
INITIATION
Target $18
JEFF
Buy
TherapeuticsMD assumed with a Buy at Jefferies
Jefferies analyst Matthew Andrews assumed coverage of TherapeuticsMD with a Buy rating and $18 price target. The analyst expects positive TX-001HR data in the coming weeks and believes the risk/reward is favorable going into the hormone replacement therapy data.
11/29/16
GUGG
11/29/16
NO CHANGE
GUGG
TherapeuticsMD selloff a buying opportunity, says Guggenheim
Guggenheim analyst Louise Chen believes weakness in TherapeuticsMD is a compelling buying opportunity. Chen said the weakness appears to be driven by a short presentation which sounds like a "rehash" of a prior short thesis published on the blog site "SeekingAlpha.com" with little new information. The analyst expects positive data for TX-001HR in 4Q16, and potential approval for Yuvvexy on its PDUFA date of 5/7/17, both of which she believes have blockbuster potential. Chen has a Buy rating on TherapeuticsMD shares.
11/30/16
STFL
11/30/16
NO CHANGE
STFL
TherapeuticsMD Phase III trial likely to be successful, says Stifel
Stifel analyst Annabel Samimy expects the Phase III trial of TherapeuticsMD's estradiol+progesterone for the treatment of vasomotor symptoms in menopausal women to show that the three highest doses of the company's drug are "efficacious." The analyst says that estradiol has successfully reduced VMS symptoms in prior trials. She keeps a $14 price target and a Buy rating on the shares.
11/30/16
JEFF
11/30/16
NO CHANGE
Target $18
JEFF
Buy
TherapeuticsMD short thesis a 'hodgepodge' that ignores '001, says Jefferies
Jefferies analyst Matthew Andrews attributes yesterday's slide in TherapeuticsMD to a short thesis presented by an investor at the Robin Hood Conference, though he views the thesis as a "hodgepodge" of topics, many of which have already been expressed by bears. Andrews said nothing in the short call impacts his expectation for positive REPLENISH trial data and sales of Yuvvexy and TX-001HR. He keeps a Buy rating and $18 price target on TherapeuticsMD shares.

TODAY'S FREE FLY STORIES

ICPT

Intercept

$73.70

-24.42 (-24.89%)

09:31
09/22/17
09/22
09:31
09/22/17
09:31
Downgrade
Intercept rating change  »

Citi downgrades Intercept…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MHK

Mohawk

09:31
09/22/17
09/22
09:31
09/22/17
09:31
Downgrade
Mohawk rating change  »

Mohawk downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UFCS

United Fire Group

$42.02

-0.12 (-0.28%)

09:30
09/22/17
09/22
09:30
09/22/17
09:30
Upgrade
United Fire Group rating change  »

United Fire Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/22/17
09/22
09:30
09/22/17
09:30
General news
PMI Composite Flash Manufacturing â€' Level to be reported at 09:45 »

September PMI Composite…

09:30
09/22/17
09/22
09:30
09/22/17
09:30
General news
PMI Composite Flash â€' Level to be reported at 09:45 »

September PMI Composite…

YOGA

YogaWorks

$4.00

-0.04 (-0.99%)

09:28
09/22/17
09/22
09:28
09/22/17
09:28
Recommendations
YogaWorks analyst commentary  »

YogaWorks shares remain…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

09:28
09/22/17
09/22
09:28
09/22/17
09:28
Hot Stocks
International Paper to invest about $300M to convert Riverdale paper machine »

International Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDTI

Integrated Device

$27.00

-0.16 (-0.59%)

09:26
09/22/17
09/22
09:26
09/22/17
09:26
Recommendations
Integrated Device analyst commentary  »

Integrated Device chip…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 05

    Oct

09:25
09/22/17
09/22
09:25
09/22/17
09:25
Conference/Events
DA Davidson engineering analyst holds an analyst/industry conference call »

Engineering &…

RBS

RBS

09:24
09/22/17
09/22
09:24
09/22/17
09:24
Upgrade
RBS rating change  »

RBS upgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COR

CoreSite Realty

09:23
09/22/17
09/22
09:23
09/22/17
09:23
Initiation
CoreSite Realty initiated  »

CoreSite Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CONE

CyrusOne

$60.41

-0.35 (-0.58%)

09:22
09/22/17
09/22
09:22
09/22/17
09:22
Initiation
CyrusOne initiated  »

CyrusOne initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

, S

Sprint

09:21
09/22/17
09/22
09:21
09/22/17
09:21
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: T-Mobile US…

TMUS

T-Mobile

$63.39

-0.13 (-0.20%)

S

Sprint

EARS

Auris Medical

$0.71

0.0101 (1.44%)

ASND

Ascendis Pharma

$27.74

-1.55 (-5.29%)

VSAR

Versartis

$21.60

-0.25 (-1.14%)

FINL

Finish Line

$9.22

-0.21 (-2.23%)

FL

Foot Locker

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 27

    Sep

  • 02

    Oct

  • 16

    May

BWA

BorgWarner

, SEV

Sevcon

$22.00

-0.01 (-0.05%)

09:21
09/22/17
09/22
09:21
09/22/17
09:21
Conference/Events
Sevcon to host special shareholder meeting »

Special Shareholder…

BWA

BorgWarner

SEV

Sevcon

$22.00

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ICPT

Intercept

$73.70

-24.42 (-24.89%)

09:19
09/22/17
09/22
09:19
09/22/17
09:19
Downgrade
Intercept rating change  »

Intercept downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLR

Digital Realty

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Initiation
Digital Realty initiated  »

Digital Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/22/17
09/22
09:18
09/22/17
09:18
Options
Overnight activity included 125 trades in SPX and 21 trades in VIX »

125 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CAG

Conagra Brands

09:17
09/22/17
09/22
09:17
09/22/17
09:17
Hot Stocks
Conagra Brands to acquire Angie's Artisan Treats, terms not disclosed »

Conagra Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

  • 28

    Sep

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Euro$ interest rate futures have continued to steady »

Euro$ interest rate…

09:15
09/22/17
09/22
09:15
09/22/17
09:15
General news
Breaking General news story  »

Kansas City Federal…

HDSN

Hudson Technologies

$8.47

-0.79 (-8.53%)

09:14
09/22/17
09/22
09:14
09/22/17
09:14
Recommendations
Hudson Technologies analyst commentary  »

Roth says Hudson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

ACN

Accenture

09:11
09/22/17
09/22
09:11
09/22/17
09:11
Recommendations
Accenture analyst commentary  »

Accenture risk/reward…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 02

    Oct

  • 22

    Oct

FINL

Finish Line

$9.22

-0.21 (-2.23%)

09:10
09/22/17
09/22
09:10
09/22/17
09:10
Hot Stocks
Breaking Hot Stocks news story on Finish Line »

Finish Line still sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

DKS

Dick's Sporting

$26.23

-0.31 (-1.17%)

09:05
09/22/17
09/22
09:05
09/22/17
09:05
Hot Stocks
Dick's Sporting to open four new stores in three states in September »

DICK'S Sporting Good…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

, CETX

Cemtrex

$3.21

-0.09 (-2.73%)

09:04
09/22/17
09/22
09:04
09/22/17
09:04
Hot Stocks
Bharat Parikh & Associates responds to Key Tronic's allegations »

Bharat Parikh &…

KTCC

Key Tronic

$6.84

-0.023 (-0.34%)

CETX

Cemtrex

$3.21

-0.09 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.